1 / 27

HEPATITIS C VIRUS

HEPATITIS C VIRUS. Presented By: Rabia Ejaz Tahira Karim Hafsa Iftikhar. TABLE OF CONTENTS: Introduction Structure Genome Genotype Life cycle Hepatitis C Risk factors Symptoms IDUs Prevalence Classification Treatmen t. INTRODUCTION:

keiki
Download Presentation

HEPATITIS C VIRUS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HEPATITIS C VIRUS Presented By: RabiaEjaz TahiraKarim HafsaIftikhar

  2. TABLE OF CONTENTS: • Introduction • Structure • Genome • Genotype • Life cycle • Hepatitis C • Risk factors • Symptoms • IDUs • Prevalence • Classification • Treatment

  3. INTRODUCTION: • HCV was discovered in 1989 as the major causative agent of non-A, non-B hepatitis. • It is plus stranded RNA virus. • Hepatitis C virus (HCV) is a small (55–65 nm in size), enveloped, positive-sense single-strandedRNA virus of the family Flaviviridae. Hepatitis C virus is the cause of hepatitis C in humans. • Hepatitis C virus mutate rapidly.

  4. STRUCTURE: • Heptitis C virus particle consist of core of genetic material (RNA) • It is surrounded by icosahedral protein •  further encased in a lipid (fatty) envelope of cellular origin. • Two viral envelope glycoproteins, E1 and E2, are embedded in the lipid envelope.

  5. GENOME • Hepatitis C virus genome is positive sense single stranded RNA genome. • at 5’ and 3’ end of RNA are UTR that are not translated into proteins but are important to translation and replication of viral RNA. • Genome is composed of both structural and non-structural proteins.

  6. GENOTYPES • There are eleven genotypes of HCV of which six are major genotypes. • genotype 3 is most common in pakistan • In 1997 it was reported in a small study that the 87% individuals in Pakistan had genotype 3 . • In 2004, a panel of 30 top gastroenterologist of the country met in a conference and reported that 75%-90% HCV patients in Pakistan had genotype 3a. • Qazi et al in 2006 reported that 71% patients had genotype 3 while only 10% had genotype 1. • In 2007 it was reported that 81% individuals had genotype 3 while only 9.5% had genotype 1.

  7. LIFE CYCLE OF HEATITIS C VIRUS

  8. INTRODUCTION: Hepatitis C is a viral disease that leads to swelling (inflammation) of the liver. Hepatitis C is an infection of the liver caused by the Hepatitis C Virus (HCV). The hepatitis C virus (HCV) is a virus that infects the liver, and can cause inflammation and scarring of the liver. The initial phase of HCV infection is called acute hepatitis C. If the virus persists in the body for more than six months, the disease enters the chronic hepatitis C phase. .

  9. HIGH RISK FACTORS: • Blood transfusion • Barber • Unnecassry and unsave needles • Breast feeding • Babies born to infected mothers • Heamodialysis

  10. LOWER RISK FACTOR: • sharing personal hiegene item with infected • person(toothbrushes , razors ,scissors and nail clippers) • Contaminated tattoo needles and ink • contaminated body piercing implements

  11. SYMPTOMS: • The HCV infection takes years to produce symptoms in those infected with this virus. About 35% of the infected people may produce symptoms while the rest may not produce symptoms at all. HCV does not have prominent symptoms in the early stage. The infected individual may experience vague symptoms such as  • abdominal pain • impaired digestion • loss of appetite • lassitude • weakness • itching

  12. Patients in the advanced stage may experience more severe symptoms such as • paleness (whiteness) of eyes • loss of appetite • depression • bleeding from rectum • bloody vomiting • exhaustion • weight loss • Advanced stage symptoms of Hepatitis C are those due to chronic inflammation of liver (hepatitis), cirrhosis (scarring of tissues) of liver and/or liver failure. 

  13. HCV in Injecting Drug Users (IDUs) • It was estimated that there was about 5 million drug users in Pakistan out of which 15% were regular IDUs. • There is an increase shift among addicts from inhalatory to injectable drugs due to decrease in quality and availability of heroin (common inhalatory drug used in Afghanistan and Pakistan) .

  14. Prevalence in Pakistan: • There are various reports regarding HCV seroprevalence in IDUs from different areas of Pakistan. It was reported that HCV seroprevalence in Karachi population was 94 %. • Kuo et al in 2006, reported that HCV seroprevalence in IDUs population of Lahore and Quetta was 88%, in a separate study from Quetta it was reported that HCV seroprevalence was 60%. HCV seroprevalence among the IDUs of Rawalpindi and Abottabad was 17.3% and 8% respectively

  15. Incubation period • 2-25 weeks • average 7-9 weeks • Virus enter the body • Binds & enters cell (usually liver receptor) • Virus loses lipid coat and polyprotein envelop – freeing RNA • Enzymes in the cell make large viral protein to help make new viral RNA • Virus releases new virus into blood and eventually kills host cell • Replication - > 1 trillion per day

  16. HEPATITIS C classification ACUTE HEPATITIS CHRONIC HEPATITIS • Acute hepatitis is the rapid, sharp, painful onset of the disease. Acute symptoms are more painful for patients, but they last for only three or four weeks. Depending on the patient's immune system, acute symptoms range from mild to severe liver failure • chronic hepatitis is less common and symptoms are less severe. Chronic hepatitis remains in the patient's system for months or even years. Its symptoms are usually mild, but continual infection and destruction of the tissue causes liver damage leading to cirrhosis. Cirrhosis is caused by scarring of the liver, and it can lead to failure or liver cancer.

  17. TREATMENT FOR HCV • Interferon: • Interferon is the only agent of proven efficacy in the treatment of  hepatitis C. Standard treatment is interferon alfa-2b at a dose of three million  units three times a week. The initial course of treatment is 6 months, but require retreatment. • The goal of interferon  treatment is suppression of active disease; this usually requires long term  therapy. • Eradication of virus does not appear to be a realistic goal in most  patients • .

  18. Ribavarin: • It inhibit the replication of RNA virus in cell culture. • It is an anti-viral drug which is nucleoside analog.It is taken orally twice a day. • It decreases hepatitis C virus infectivity in a dose treatment manner • The exact way ribavirin work when it enter the cell is unknown.

  19. Side effects • Interferon • Fatigue • Muscle/Joint pain • Nausea • Headaches • Anxiety • Depression • Dry Skin/rashes • Ribavirin • seems to make interferon side effects worse – especially fatigue-Anemia

  20. SHARE TO LEARN AND MOVE AHEAD

More Related